MCU and Parkinson disease: Our data showing down-regulation of MICU2 and MICU3 in human PD brain combined with the observation that MCU inhibition reduces α-syn pathology in primary neurons corroborates the potential role for dysfunction of the MCU complex in PD pathogenesis.